Trademark: 88095267
Word
OPTIBUMIN
Status Date
Tuesday, May 14, 2019
Registration Number
5749521
Registration Date
Tuesday, May 14, 2019
Filing Date
Tuesday, August 28, 2018
Published for Opposition
Tuesday, February 26, 2019
5 Recombinant albumin for biological therapeutic purposes; Recombinant albumin for use as a reagent for medical use, namely, in-vitro fertilization, tissue sealant, tissue and cell cryopreservation, and blood detoxification
1 Recombinant albumin in the nature of excipients for use in the manufacture of pharmaceutical preparations, cellular therapies, gene therapies and vaccines; Recombinant albumin for use as a reagent for scientific and research use, namely, biomedical research and development
The mark consists of the word "OPTIBUMIN" under a tapering arc whose wider end begins at the top right of the letter "O".
Color is not claimed as a feature of the mark.
Sep 13, 2023
Automatic Update Of Assignment Of Ownership
May 14, 2019
Registered-Principal Register
Feb 26, 2019
Official Gazette Publication Confirmation E-Mailed
Feb 26, 2019
Published For Opposition
Feb 6, 2019
Notification Of Notice Of Publication E-Mailed
Jan 20, 2019
Assigned To Lie
Jan 4, 2019
Approved For Pub - Principal Register
Jan 3, 2019
Teas/Email Correspondence Entered
Jan 2, 2019
Correspondence Received In Law Office
Jan 2, 2019
Teas Response To Office Action Received
Nov 2, 2018
Notification Of Examiner's Amendment/Priority Action E-Mailed
Nov 2, 2018
Examiner's Amendment/Priority Action E-Mailed
Nov 2, 2018
Combined Examiner's Amendment/Priority Action Automatic Entry
Nov 2, 2018
Examiners Amendment And/Or Priority Action - Completed
Nov 1, 2018
Assigned To Examiner
Sep 7, 2018
Notice Of Design Search Code E-Mailed
Sep 6, 2018
New Application Office Supplied Data Entered
Aug 31, 2018
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
